Methyldihydromorphine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Methyldihydromorphine
Dihydroheterocodeine.png
Systematic (IUPAC) name
(5α,6α)-6-Methoxy-17-methyl-4,5-epoxymorphinan-3-ol
Clinical data
Legal status Schedule I (US)
Identifiers
CAS number 7732-92-5 YesY
ATC code None
PubChem CID 5463907
UNII 26AY9TLO5W N
Synonyms Dihydroheterocodeine
Chemical data
Formula C18H23NO3 
Mol. mass 301.38 g/mol
 N (what is this?)  (verify)

Methyldihydromorphine (Dihydroheterocodeine)[1] is a semi-synthetic opioid originally developed in Germany in 1936, controlled under both domestic law and UN conventions because of its possible potential for abuse. Methyldihydromorphine is related to heterocodeine and is not a synonym for dihydrocodeine. Its structure suggests that it is six to nine times stronger than morphine and 72 times stronger than dihydrocodeine.

So far, little is currently known about this compound. It is a Schedule I controlled substance in the United States with an ACSCN of 9304 and a 2013 annual manufacturing quota of 2 grammes.[2]

References[edit]